{"title":"Mucormycosis - A Rare, yet Lethal Infection: A Review","authors":"Arvind Sethuraman Vairavan Charles, Naveed Sohaira, Ala Sidheeq Aminath, Anthonette Nivetha Sethu Raman Vairavan Christina, Suryadevara Nagaraja","doi":"10.25303/1711rjbt1270135","DOIUrl":null,"url":null,"abstract":"Mucormycosis is an angio invasive infection caused by Mucorales fungi, which is mostly observed in diabetic and immunocompromised patients. The infection can be classified into cutaneous, rhino-orbito cerebral, gastrointestinal, disseminated and other rare pulmonary types. The overall mortality rate due to this infection has increased, even with aggressive treatment. Moreover, there has been a major mucormycosis outbreak in India following the deadly second wave of COVID-19 cases in the country. The epidemiology of mucormycosis is evolving due to advances in therapeutics and early diagnostics tools. The aim of this review is to provide an overview of the epidemiology, pathogenesis and types of mucormycosis along with an update on the recent advanced diagnostics tools and therapeutics to combat the rare, yet lethal infection.","PeriodicalId":21091,"journal":{"name":"Research Journal of Biotechnology","volume":" ","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2022-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research Journal of Biotechnology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25303/1711rjbt1270135","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0
Abstract
Mucormycosis is an angio invasive infection caused by Mucorales fungi, which is mostly observed in diabetic and immunocompromised patients. The infection can be classified into cutaneous, rhino-orbito cerebral, gastrointestinal, disseminated and other rare pulmonary types. The overall mortality rate due to this infection has increased, even with aggressive treatment. Moreover, there has been a major mucormycosis outbreak in India following the deadly second wave of COVID-19 cases in the country. The epidemiology of mucormycosis is evolving due to advances in therapeutics and early diagnostics tools. The aim of this review is to provide an overview of the epidemiology, pathogenesis and types of mucormycosis along with an update on the recent advanced diagnostics tools and therapeutics to combat the rare, yet lethal infection.
期刊介绍:
We invite you to contribute Research Papers / Short Communications / Review Papers:
-In any field of Biotechnology, Biochemistry, Microbiology and Industrial Microbiology, Soil Technology, Agriculture Biotechnology.
-in any field related to Food Biotechnology, Nutrition Biotechnology, Genetic Engineering and Commercial Biotechnology.
-in any field of Biotechnology related to Drugs and Pharmaceutical products for human beings, animals and plants.
-in any field related to Environmental Biotechnolgy, Waste Treatment of Liquids, Soilds and Gases; Sustainability.
-in inter-realted field of Chemical Sciences, Biological Sciences, Environmental Sciences and Life Sciences.
-in any field related to Biotechnological Engineering, Industrial Biotechnology and Instrumentation.
-in any field related to Nano-technology.
-in any field related to Plant Biotechnology.